https://www.selleckchem.com/pr....oducts/3,4-dichlorop
Several treatment modalities are available for patients with stage I non-small cell lung cancer (NSCLC). Over the past decade, these treatment modalities have been further investigated and might have changed current treatment regimens. In this review we present an overview of the treatment options, developments and future perspectives for stage I NSCLC. Furthermore, we describe the current use of these treatment modalities in the Netherlands. A bibliographical search was performed in PubMed and the Cochrane Lib
Respect!
Kommentar
Delen
